CA
AMGN icon

Chatterton & Associates’s Amgen AMGN Stock Holding History

Chatterton & Associates’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-744
Closed -$265K – 102
2026
Q1 		$265K Sell
744
-30
-4% -$10.7K 0.19% 80
2025
Q4 		$253K Buy
+774
New +$246K 0.22% 67

Other funds holding AMGN

Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Chatterton & Associates's AMGN Position: Q2 2026 in Review

Chatterton & Associates sold out of Amgen (AMGN) in Q2 2026, closing a stake of 744 shares — an estimated $265K sold.

Chatterton & Associates first reported a position in AMGN in Q4 2025 and held it in 2 quarters. The position peaked at $265K in Q1 2026. 1,943 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Chatterton & Associates reported no remaining Amgen position as of Q2 2026 after selling out during the quarter.
  • Chatterton & Associates sold 744 Amgen shares in Q2 2026, an estimated $265K.
  • Chatterton & Associates first reported a position in Amgen in Q4 2025 and held it in 2 quarters.
  • Chatterton & Associates's Amgen position peaked at $265K in Q1 2026.
  • 1,943 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Chatterton & Associates's 13F filing for Q2 2026, filed 14 Jul 2026.